ALLO peer analysis
Allogene Therapeutics (ALLO) against its competitors: price, today's move, 1-year return and market value side by side.
ALLO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ATRA Atara Biotherapeutics | $8.01 | -7.51% | -43.03% | $80.40M |
| AUTL Autolus Therapeutics | $1.52 | -3.80% | 0.66% | $404.57M |
| CELU Celularity | $0.80 | -5.79% | -57.67% | – |
| CLLS Cellectis | $1.08 | -7.69% | -68.97% | $108.79M |
| CRBU Caribou Biosciences | $0.42 | -4.90% | -81.76% | – |
| DTIL Precision BioSciences | $7.06 | -5.11% | -18.00% | $194.87M |
| FATE Fate Therapeutics | $2.08 | -4.15% | 61.24% | $249.23M |
| IPSC Century Therapeutics | $1.47 | 0.68% | 148.31% | – |
| ALLO Allogene Therapeutics | $1.18 | -5.60% | -2.48% | $407.68M |
- ALLO's peers: ATRA (Atara Biotherapeutics), AUTL (Autolus Therapeutics), CELU (Celularity), CLLS (Cellectis), CRBU (Caribou Biosciences), DTIL (Precision BioSciences), FATE (Fate Therapeutics), IPSC (Century Therapeutics).
Updated 2026-11-02 17:56 UTC